Previous close | 1.8000 |
Open | 1.5900 |
Bid | 0.0000 |
Ask | 3.0000 |
Strike | 775.00 |
Expiry date | 2024-05-17 |
Day's range | 1.5800 - 4.3200 |
Contract range | N/A |
Volume | |
Open interest | 5 |
First Quarter Results Show Revenue Decline but Strong Dupixent and Libtayo Sales Growth
It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...
Regeneron Pharmaceuticals earnings and sales missed first-quarter estimates early Thursday. Shares fell slightly.